Vor Biopharma Inc. (VOR) stock
VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$19.32−0.77 (-3.83%)
Close on Nov 12, 2026Market cap $1.19BP/E –Yield –
Vor Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vor Biopharma's enterprise value was $627.92M on Nov 11, 2026, against -$95.31M a year earlier. Over the last 5 years it ranged from -$95.31M to $758.07M, with a median of $18.98M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $627.92M | – |
| 2025 | Dec 31, 2025 | -$52.43M | -490.8% |
| 2024 | Dec 31, 2024 | $13.42M | – |
| 2023 | Dec 29, 2023 | -$7.58M | -106.4% |
| 2022 | Dec 30, 2022 | $119.25M | -41.6% |
| 2021 | Dec 31, 2021 | $204.18M | – |
See a number that looks wrong?